CNS Pathology case based MCQs-2

CASE : The spinal MRI of a 22-year old male with neurofibromatosis type-2 showed a hyperintense lesion. The lesion was resected and histopathologic section is shown in image.

Question 1: What is the diagnosis?

A. Medulloblastoma
B. Ependymoma
C. Retinoblastoma
D. Central neurocytoma

Question 2: Which of the following statements is true regarding this tumor?

A. They are predominantly supratentorial
B. Posterior fossa tumors in adults have a good prognosis
C. Spinal tumors have a bad prognosis
D. IDH 1 and 2 mutations are present in 100% cases.

Question 3: Identify the variant of the tumor shown in the image below.

A. Tancytic
B. Myxopapillary
C. Subependymoma
D. Anaplastic

Question 4: Which of the following statements is true regarding tancytic ependymoma?

A. GFAP negative
B. Abundant rosettes
C. Can be confused with pilocytic astrocytoma
D. WHO Grade 1

Question 5: Identify the FALSE statement regarding the variant of ependymoma shown below

Image credit- http://www.twitter.com/DrAldehyde

A. WHO Grade 1
B. Arises from filum terminale
C. Aggressive clinical course
D. Mucin stains positive

Question 6: TRUE statement regarding recent molecular classification (WHO CNS 2021 5th edition ) of ependymoma is

A. Spinal ependymomas with MYCN have a good prognosis
B. ZFTA Fusion- favorable prognosis
C. YAP Fusion- poor prognosis
D. Spinal ependymomas with NF 2 mutation- favorable prognosis

ANSWER- Question 1

Correct answer is B- Ependymoma

Ependymomas are characterized by perivascular rosettes and ependymal rosettes which have an empty central lumen

Types of rosettes
ANSWER- Question 2

CORRECT ANSWER IS B

🐱 Majority of of Ependymomas are infratentorial.

🐱Posterior fossa tumors in children have a poor prognosis (PF-A)- associated with loss of H3K27me, whereas Posterior fossa tumors in adults have a god prognosis (PF-B)- H3K27me is retained.

🐱 Spinal ependymomas have a good prognosis, whereas a small number of ependymomas associated with MYCN have a poor outcome.

🐱IDH 1 and 2 are associated with astroctyomas and oligodendroglomas but nor ependymomas.

ANSWER-Question 3

CORRECT ANSWER IS A

Diagnosis is TANCYTIC EPENDYMOMA, 🐱 Tancytes are cells with fibrillary processes which line ventricles along with ependymal cells.

Types of tancytes
ANSWER – Question 4

Correct They are GFAP positive 🐱Confused with pilocytic astrocytoma because of the prominent fibrillary projections 🐱It is a GRADE II Ependymoma 🐱 Ependymal rosettes and pseudorosettes are scanty in tanytic ependymoma, which makes diagnosis challenging.

ANSWER- Question 5

Correct answer is C
💀Diagnosis is myxopapillary ependymoma
💀It is a Grade II Tumor according to latest WHO
💀It is common in adults and arises from the filum terminale
💀It is clinically indolent ( nor aggressive)
💀Stains for Mucin is positive.

Mucin stains positive in myxopapillary ependymoma
ANSWER – Question 6

Correct answer is D

Spinal ependymomas with NF2 mutation has a good prognosis

Summary of latest molecular updates in ependymoma

Central nervous system (CNS) tumors pathology mcq pdf with answers

CNS pathology questions with answers- DOWNLOAD PDF

Central nervous system tumors pathology mcq pdf with answers – Useful for NEET-SS Oncopathology, DM Histopathology, NIMHANS- Neuropathology fellowships and FRCPath-Histopathology.

You may join telegram channel for topicwise mcqs- Pathology mcqs

For pathology mcqs, quizzes, interesting facts and updates – Visit HOME – Pathology for all

Join the Facebook page for daily questions- Pathology mcq

Useful for NEET-SS Oncopathology, DM Histopathology, FRCPath, and Hematopathology fellowships.

RECENT BLOGS

5 ways to differentiate gliosis and glioma.

Gliosis is often confusing and challenging to differentiate from glioma. Adding to the trouble, is the fact that gliomas often accompany gliosis. Therefore it is essential to differentiate gliosis and gliomas.

5 ways to differentiate gliosis and glioma

Gliosis is also seen in demyelinaying diseases and infections

Ideally ‘gliosis with glioma’ and ‘gliosis without glioma’ shoud be differentiated, but to keep things simple let’s look at a few clues to tell the two apart.

GLIOMAS Vs GLIOSIS

1. MITOSIS

Mitosis naturally is characteristic of multiplying cells. Hence mitosis is lower in gliosis when compared to glioma. As a general rule the Ki67 proliferation index does not exceed > 5% in gliosis.

This isn’t entirely useful, because low grade gliomas do not show mitosis. Ki-67 stains may be useful to quantify mitosis by immunohistochemistry.

2. MARGINS

This is probably the most important differentiating fearure.

GLIOMAS- EXPAND

GLIOSIS- CONTRACTS

However important this finding is, it is difficult to confirm without serial radiographs.

3. CELLULAR DENSITY

Gliosis- cellular density is even

Glioma- cellular density is uneven

4. NUCLEUS

Gliosis- nuclei of cells don’t touch each other.

Glioma- nuclei of cells often touch each other.

5. IMMUNOHISTOCHEMICAL MARKERS

Gliosis- negative for markers such as IDH and p53.

Glioma- positive for markers such as IDH and p53.

IDH and p53 are not positive in many gliomas but, when they are positive they can be diagnostic.

In this context it would be fitting to discuss quickly about a condition which often mimicks brain tumor- GLIOMATOSIS CEREBRI

Gliomatosis cerebri is a rare primary brain tumor. It is commonly characterized by diffuse infiltration of the brain with neoplastic glial cells that affect various areas of the cerebral lobes. Gliomatosis cerebri behaves like a malignant tumor that is very similar to Glioblastoma.

Though it is not an easy task to differentiate gliomas and gliomas, hope these tips would be of some use.

Thank you!

To read similar posts click here

Click here for YouTube video